↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

116 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   98% dehydrated alcohol   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
298 
 2   A04ad10   -   -   -   -   1件:
298 
 3   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 4   Acetyl-l-carnitine   Acetylcarnitine   -   -   -   1件:
298 
 5   Acetyl-l-carnitine 1000mg 2x per day for 3 months   Acetylcarnitine   -   -   -   1件:
298 
 6   Acetylcysteine   Acetylcysteine   D00221   -   -   14件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 7   Alanine   L-alanine   D00012   -   -   3件:
13,
298,
299 
 8   Alcohol   Ethanol   D00068, D02798, D04855, D06542   -   -   4件:
13,
58,
279,
298 
 9   Alpha 1-antitrypsin   Alpha-1-proteinase inhibitor   -   -   -   1件:
298 
 10   Amino acids   Amino acids   -   -   -   4件:
70,
90,
240,
298 
 11   Amlodipine   Amlodipine   D00615, D02914, D07450   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
51,
65,
67,
298 
 12   Amlodipine (drug)   Amlodipine   D00615, D02914, D07450   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
298 
 13   Analgesics   -   -   -   -   1件:
298 
 14   Antioxidant plus pregabalin   Pregabalin   D02716   4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4   7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway   1件:
298 
 15   Antioxidants   -   -   -   -   4件:
90,
298,
301,
310 
 16   Antox (vers.)1.2   -   -   -   -   1件:
298 
 17   Antox version 1.2   -   -   -   -   1件:
298 
 18   Autologous mesenchymal stromal cell   -   -   -   -   2件:
96,
298 
 19   Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala)   L-alanine   D00012   -   -   1件:
298 
 20   Bupivacaine   Bupivacaine   D01450, D07552   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   7件:
46,
53,
70,
96,
168,
226,
298 
 21   Bupivacaine & triamcinolone acetonide   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
298 
 22   Bupivicaine alone   -   -   -   -   1件:
298 
 23   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 24   Calcium, dietary   Calcium   -   -   -   1件:
298 
 25   Carbon   Activated charcoal   D03251   -   -   7件:
6,
46,
85,
86,
96,
97,
298 
 26   Carbon monoxide   Carbon monoxide   D09706   -   -   3件:
85,
86,
298 
 27   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 28   Cholecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   9件:
13,
19,
34,
46,
49,
96,
97,
298,
299 
 29   Creon   Pancrelipase amylase   -   -   -   2件:
298,
299 
 30   Creon 10000   Pancrelipase amylase   -   -   -   2件:
298,
299 
 31   Creon 25000   Pancrelipase amylase   -   -   -   2件:
298,
299 
 32   Creon36™   -   -   -   -   1件:
298 
 33   Diazepam   Diazepam   D00293   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   3件:
46,
155,
298 
 34   Dronabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   5件:
2,
13,
46,
271,
298 
 35   Ensure surgical   -   -   -   -   1件:
298 
 36   Esomeprazole   Esomeprazole   D01984, D04056, D07917, D09339   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   6件:
6,
46,
86,
98,
298,
299 
 37   Etanercept   Etanercept   D00742   2件: LTA, TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   14件:
15,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298 
 38   Eur-1008 (apt-1008) high dose   -   -   -   -   1件:
298 
 39   Eur-1008 (apt-1008) low dose   -   -   -   -   1件:
298 
 40   Eur-1066-a   -   -   -   -   1件:
298 
 41   Eur-1066-b   -   -   -   -   1件:
298 
 42   Fluimucil*20cpr eff 600mg   -   -   -   -   2件:
94,
298 
 43   Gabapentin   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   5件:
6,
13,
19,
70,
298 
 44   Gabapentin prescriptions   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
298 
 45   Helopanflat mono®   -   -   -   -   1件:
298 
 46   Hemoglobin   Hemoglobin   -   -   -   1件:
298 
 47   Human secretin   Secretin human   -   -   -   1件:
298 
 48   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 49   Intra plexus triamcinolone and bupivicaine injection   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
298 
 50   Kreon 25000   -   -   -   -   2件:
298,
299 
 51   L-carnitine   Levocarnitine   D02030, D02176, D04713   -   -   6件:
13,
96,
97,
265,
298,
316 
 52   Lanreotide   Lanreotide   D04666   -   -   4件:
67,
73,
85,
298 
 53   Lanreotide acetate   Lanreotide   D04666   -   -   3件:
73,
85,
298 
 54   Lipase   -   -   -   -   1件:
298 
 55   Liprotamase   -   -   -   -   2件:
298,
299 
 56   Lyrica   Pregabalin   D02716   4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4   7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway   1件:
298 
 57   Lyrica®   -   -   -   -   1件:
298 
 58   Magnesium   Magnesium   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 59   Mezym f   -   -   -   -   1件:
298 
 60   Midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 61   Monitor   Methamidophos   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300 
 62   Ms1819   Ms1819   -   -   -   2件:
298,
299 
 63   Ms1819-sd   Ms1819   -   -   -   2件:
298,
299 
 64   Multienzymes (lipase, protease etc.)   -   -   -   -   1件:
298 
 65   Namisol   -   -   -   -   2件:
13,
298 
 66   Nexium (esomeprazole magnesium)   Esomeprazole   D01984, D04056, D07917, D09339   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   1件:
298 
 67   Ni-03   -   -   -   -   1件:
298 
 68   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 69   Oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   7件:
6,
13,
46,
70,
226,
231,
298 
 70   Oxycodone depot ”sandoz”, depot tablets   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
298 
 71   Oxycodone hydrochloride   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   3件:
70,
226,
298 
 72   Oxycodonhydrochlorid ”lannacher”, depot tablets   -   -   -   -   1件:
298 
 73   Oxynorm   -   -   -   -   1件:
298 
 74   Pancreatic enzymes   -   -   -   -   1件:
298 
 75   Pancreatin   Pancrelipase   D05349   -   -   2件:
298,
299 
 76   Pancrelipase   Pancrelipase   D05349   -   -   4件:
96,
97,
298,
299 
 77   Pancrelipase delayed release capsule   Pancrelipase   D05349   -   -   2件:
298,
299 
 78   Pancrelipase/pancreas powder   Pancrelipase   D05349   -   -   2件:
298,
299 
 79   Panzytrat   Pancrelipase   D05349   -   -   2件:
298,
299 
 80   Panzytrat 25.000   Pancrelipase   D05349   -   -   1件:
298 
 81   Panzytrat 25.000 fip-e units of lipase   Pancrelipase   D05349   -   -   1件:
298 
 82   Pentoxifylline   Pentoxifylline   D00501   -   -   10件:
26,
56,
84,
93,
96,
113,
220,
222,
296,
298 
 83   Perflubutane   Perflubutane   D05440   -   -   2件:
298,
300 
 84   Pioglitazone   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 85   Pl 00512/0150   -   -   -   -   1件:
298 
 86   Pregabalin   Pregabalin   D02716   4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4   7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway   5件:
13,
36,
46,
70,
298 
 87   Prolastin-c   Alpha-1-proteinase inhibitor   -   -   -   2件:
231,
298 
 88   Proton pump inhibitor (ppi)   -   -   -   -   1件:
298 
 89   Recombinant microbial lipase   -   -   -   -   1件:
298 
 90   Regn475/sar164877   -   -   -   -   1件:
298 
 91   Reparixin   Reparixin   D08984   2件: CXCR1, CXCR2   7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor   2件:
298,
299 
 92   Rg1068 (synthetic human secretin)   Secretin human   -   -   -   1件:
298 
 93   Rvg 13760   -   -   -   -   1件:
298 
 94   S-ketamin   -   -   -   -   1件:
298 
 95   Sa-001   -   -   -   -   1件:
298 
 96   Secretin   Secretin human   -   -   -   1件:
298 
 97   Simvastatin   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 98   Slv339   -   -   -   -   1件:
298 
 99   Somatuline autogel 90 mg   Lanreotide   D04666   -   -   1件:
298 
 100   Soy bread   -   -   -   -   1件:
298 
 101   Synthetic human secretin   Secretin human   -   -   -   1件:
298 
 102   Tanezumab   Tanezumab   D09387   1件: NGF   8件: Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway   2件:
226,
298 
 103   Tetrahydro-6,6,9-tri methyl-3-penthyl-6 h-dibenzo[ b,d ]pyran-1-ol   -   -   -   -   1件:
298 
 104   Tetrahydrocannabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   2件:
13,
298 
 105   Thalidomide   Thalidomide   D00754   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 106   Triamcinolone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
35,
46,
56,
70,
90,
96,
226,
298 
 107   Viokase   Pancrelipase   D05349   -   -   1件:
298 
 108   Viokase 16   Pancrelipase   D05349   -   -   1件:
298 
 109   Viokase 16 (pancrelipase) + nexium   Pancrelipase   D05349   -   -   1件:
298 
 110   Viokase® 16   Pancrelipase   D05349   -   -   1件:
298 
 111   Vitamin d   Vitamin d   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 112   Vitamin d 100ug   Vitamin d   -   -   -   1件:
298 
 113   Vitamin d 10ug   Vitamin d   -   -   -   1件:
298 
 114   Yarrowia lipolytica lipase   -   -   -   -   1件:
298 
 115   Zenpep   Pancrelipase amylase   -   -   -   2件:
298,
299 
 116   Zentase   -   -   -   -   1件:
298 

先頭へ